Tax

State & Local Tax (Deferred)

Vertex Pharmaceuticals State & Local Tax (Deferred) remained flat by 0.0% to -$5.53M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 54.6%, from -$12.18M to -$5.53M. Over 2 years (FY 2023 to FY 2025), State & Local Tax (Deferred) shows relatively stable performance with a 0.5% CAGR.

Analysis

StatementIncome Statement
SectionTax
CategoryRisk
SignalContext dependent
VolatilityStable
First reportedQ1 2013
Last reportedQ4 2025

How to read this metric

Reflects the company's management of state-level tax timing and potential future cash outflows.

Detailed definition

The portion of the income tax provision that represents future tax liabilities or assets resulting from temporary differ...

Peer comparison

Standard accounting metric for companies with significant state-level tax footprints.

Metric ID: is_msft_deferred_state_and_local_tax_expense

Historical Data

3 years
 FY'23FY'24FY'25
Value-$21.90M-$48.70M-$22.10M
YoY Change—-122.4%+54.6%
Range-$48.70M – -$21.90M
CAGR+0.5%
Avg YoY Growth-33.9%
Median YoY Growth-33.9%

Frequently Asked Questions

What is Vertex Pharmaceuticals's state & local tax (deferred)?
Vertex Pharmaceuticals (VRTX) reported state & local tax (deferred) of -$5.53M in Q4 2025.
How has Vertex Pharmaceuticals's state & local tax (deferred) changed year-over-year?
Vertex Pharmaceuticals's state & local tax (deferred) increased by 54.6% year-over-year, from -$12.18M to -$5.53M.
What is the long-term trend for Vertex Pharmaceuticals's state & local tax (deferred)?
Over 2 years (2023 to 2025), Vertex Pharmaceuticals's state & local tax (deferred) has grown at a 0.5% compound annual growth rate (CAGR), from -$21.90M to -$22.10M.
What does state & local tax (deferred) mean?
The portion of state and local income tax expense that is deferred to future periods due to timing differences.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.